News: $ATRS Antares Pharma Reports First Quarter 2019 Operating and Financial Results
EWING, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”) today reported operating and financial results for the first quarter ended March 31, 2019. The Company reported revenue of $23.3 million and a net loss per share of $0.03 fo...